Search

Karen L Cheal

from Cazenovia, NY
Age ~53

Karen Cheal Phones & Addresses

  • 3843 Wellington Dr, Cazenovia, NY 13035 (315) 655-9412
  • 466 Green St, Cambridge, MA 02139
  • 15 Pearl St, Cambridge, MA 02139
  • 777 Middlefield Rd, Mountain View, CA 94043
  • Sunnyvale, CA
  • San Francisco, CA
  • San Jose, CA
  • 466 Green St APT 8, Cambridge, MA 02139

Work

Position: Administrative Support Occupations, Including Clerical Occupations

Publications

Us Patents

Biological Markers For Evaluating Therapeutic Treatment Of Inflammatory And Autoimmune Disorders

View page
US Patent:
20020072484, Jun 13, 2002
Filed:
Sep 20, 2001
Appl. No.:
09/956757
Inventors:
Susan Alters - Palo Alto CA, US
Karen Cheal - Mountain View CA, US
Aaron Kantor - San Carlos CA, US
International Classification:
C12Q001/68
G01N033/567
A61K031/00
US Classification:
514/001000, 435/007210, 435/006000
Abstract:
Novel biological markers indicative of the action of an anti-inflammatory or immunosuppressive drug can be used to evaluate drug efficacy and compare local and systemic drug effects. They can also aid in comparison of different drugs, doses, and delivery routes. The biological markers include cell populations, cell surface antigen expression levels, and soluble factor concentrations. Measurement values of the novel biomarkers were shown to change significantly in allergic, atopic asthmatic, and healthy subjects after administration of prednisone.

Biological Markers For Evaluating Therapeutic Treatment Of Inflammatory And Autoimmune Disorders

View page
US Patent:
20050002862, Jan 6, 2005
Filed:
May 12, 2004
Appl. No.:
10/845473
Inventors:
Susan Alters - Palo Alto CA, US
Karen Cheal - Mountain View CA, US
Aaron Kantor - San Carlos CA, US
International Classification:
A61K049/00
G01N033/53
US Classification:
424009100, 435007100
Abstract:
Novel biological markers indicative of the action of an anti-inflammatory or immunosuppressive drug can be used to evaluate drug efficacy and compare local and systemic drug effects. They can also aid in comparison of different drugs, doses, and delivery routes. The biological markers include cell populations, cell surface antigen expression levels, and soluble factor concentrations. Measurement values of the novel biomarkers were shown to change significantly in allergic, atopic asthmatic, and healthy subjects after administration of prednisone.
Karen L Cheal from Cazenovia, NY, age ~53 Get Report